These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

312 related items for PubMed ID: 31343413

  • 1. Profiling of mRNA of interstitial fibrosis and tubular atrophy with subclinical inflammation in recipients after kidney transplantation.
    Fu Q, Liao M, Feng C, Tang J, Liao R, Wei L, Yang H, Markmann JF, Chen K, Deng S.
    Aging (Albany NY); 2019 Jul 25; 11(14):5215-5231. PubMed ID: 31343413
    [Abstract] [Full Text] [Related]

  • 2. Gene Expression in Biopsies of Acute Rejection and Interstitial Fibrosis/Tubular Atrophy Reveals Highly Shared Mechanisms That Correlate With Worse Long-Term Outcomes.
    Modena BD, Kurian SM, Gaber LW, Waalen J, Su AI, Gelbart T, Mondala TS, Head SR, Papp S, Heilman R, Friedewald JJ, Flechner SM, Marsh CL, Sung RS, Shidban H, Chan L, Abecassis MM, Salomon DR.
    Am J Transplant; 2016 Jul 25; 16(7):1982-98. PubMed ID: 26990570
    [Abstract] [Full Text] [Related]

  • 3. Anti-vimentin Antibodies Present at the Time of Transplantation May Predict Early Development of Interstitial Fibrosis/Tubular Atrophy.
    Lopez-Soler RI, Borgia JA, Kanangat S, Fhied CL, Conti DJ, Constantino D, Ata A, Chan R, Wang Z.
    Transplant Proc; 2016 Jul 25; 48(6):2023-33. PubMed ID: 27569939
    [Abstract] [Full Text] [Related]

  • 4. Altered Expression of MicroRNAs Following Chronic Allograft Dysfunction with Interstitial Fibrosis and Tubular Atrophy.
    Soltaninejad E, Nicknam MH, Nafar M, Sharbafi MH, Keshavarz Shahbaz S, Barabadi M, Yekaninejad MS, Bahrami T, Ahmadpoor P, Amirzargar A.
    Iran J Allergy Asthma Immunol; 2015 Dec 25; 14(6):615-23. PubMed ID: 26725559
    [Abstract] [Full Text] [Related]

  • 5. Inflammation in Early Kidney Allograft Surveillance Biopsies With and Without Associated Tubulointerstitial Chronic Damage as a Predictor of Fibrosis Progression and Development of De Novo Donor Specific Antibodies.
    García-Carro C, Dörje C, Åsberg A, Midtvedt K, Scott H, Reinholt FP, Holdaas H, Seron D, Reisæter AV.
    Transplantation; 2017 Jun 25; 101(6):1410-1415. PubMed ID: 27163535
    [Abstract] [Full Text] [Related]

  • 6. Lower Circulating Cytotoxic T-Cell Frequency and Higher Intragraft Granzyme-B Expression Are Associated with Inflammatory Interstitial Fibrosis and Tubular Atrophy in Renal Allograft Recipients.
    Yadav B, Prasad N, Agrawal V, Agarwal V, Jain M.
    Medicina (Kaunas); 2023 Jun 20; 59(6):. PubMed ID: 37374379
    [Abstract] [Full Text] [Related]

  • 7. Changes in Urinary Microbiome Populations Correlate in Kidney Transplants With Interstitial Fibrosis and Tubular Atrophy Documented in Early Surveillance Biopsies.
    Modena BD, Milam R, Harrison F, Cheeseman JA, Abecassis MM, Friedewald JJ, Kirk AD, Salomon DR.
    Am J Transplant; 2017 Mar 20; 17(3):712-723. PubMed ID: 27597148
    [Abstract] [Full Text] [Related]

  • 8. Cell-free microRNA-148a is associated with renal allograft dysfunction: Implication for biomarker discovery.
    Nariman-Saleh-Fam Z, Bastami M, Ardalan M, Sharifi S, Hosseinian Khatib SM, Zununi Vahed S.
    J Cell Biochem; 2019 Apr 20; 120(4):5737-5746. PubMed ID: 30320905
    [Abstract] [Full Text] [Related]

  • 9. Dysregulation of urinary miR-21 and miR-200b associated with interstitial fibrosis and tubular atrophy (IFTA) in renal transplant recipients.
    Zununi Vahed S, Omidi Y, Ardalan M, Samadi N.
    Clin Biochem; 2017 Jan 20; 50(1-2):32-39. PubMed ID: 27521993
    [Abstract] [Full Text] [Related]

  • 10. The selective biomarker IL-8 identifies IFTA after kidney transplantation in blood cells.
    Matz M, Lorkowski C, Fabritius K, Wu K, Rudolph B, Frischbutter S, Brakemeier S, Gaedeke J, Neumayer HH, Mashreghi MF, Budde K.
    Transpl Immunol; 2016 Nov 20; 39():18-24. PubMed ID: 27693310
    [Abstract] [Full Text] [Related]

  • 11. A Rejection Gene Expression Score in Indication and Surveillance Biopsies Is Associated with Graft Outcome.
    Chamoun B, Caraben A, Torres IB, Sellares J, Jiménez R, Toapanta N, Cidraque I, Gabaldon A, Perelló M, Gonzalo R, O'Valle F, Moreso F, Serón D.
    Int J Mol Sci; 2020 Nov 03; 21(21):. PubMed ID: 33153205
    [Abstract] [Full Text] [Related]

  • 12. The causes, significance and consequences of inflammatory fibrosis in kidney transplantation: The Banff i-IFTA lesion.
    Nankivell BJ, Shingde M, Keung KL, Fung CL, Borrows RJ, O'Connell PJ, Chapman JR.
    Am J Transplant; 2018 Feb 03; 18(2):364-376. PubMed ID: 29194971
    [Abstract] [Full Text] [Related]

  • 13. MicroRNA regulation in blood cells of renal transplanted patients with interstitial fibrosis/tubular atrophy and antibody-mediated rejection.
    Matz M, Heinrich F, Lorkowski C, Wu K, Klotsche J, Zhang Q, Lachmann N, Durek P, Budde K, Mashreghi MF.
    PLoS One; 2018 Feb 03; 13(8):e0201925. PubMed ID: 30102719
    [Abstract] [Full Text] [Related]

  • 14. Kidney injury molecule-1 expression in human kidney transplants with interstitial fibrosis and tubular atrophy.
    Nogare AL, Veronese FV, Carpio VN, Montenegro RM, Pedroso JA, Pegas KL, Gonçalves LF, Manfro RC.
    BMC Nephrol; 2015 Feb 13; 16():19. PubMed ID: 25884518
    [Abstract] [Full Text] [Related]

  • 15. Diagnosis of interstitial fibrosis and tubular atrophy in kidney allograft: implementation of microRNAs.
    Zununi Vahed S, Samadi N, Ardalan M.
    Iran J Kidney Dis; 2014 Jan 13; 8(1):4-12. PubMed ID: 24413714
    [Abstract] [Full Text] [Related]

  • 16. Predicting kidney outcomes among Latin American patients with lupus nephritis: The prognostic value of interstitial fibrosis and tubular atrophy and tubulointerstitial inflammation.
    Rodelo J, Aguirre L, Ortegón K, Ustáriz J, Calderon L, Taborda A, Arias LF, González LA.
    Lupus; 2023 Mar 13; 32(3):411-423. PubMed ID: 36647707
    [Abstract] [Full Text] [Related]

  • 17. Chronic allograft nephropathy or interstitial fibrosis and tubular atrophy: what is in a name?
    Haas M.
    Curr Opin Nephrol Hypertens; 2014 May 13; 23(3):245-50. PubMed ID: 24626060
    [Abstract] [Full Text] [Related]

  • 18. Early urinary CCL2 is associated with the later development of interstitial fibrosis and tubular atrophy in renal allografts.
    Ho J, Rush DN, Gibson IW, Karpinski M, Storsley L, Bestland J, Stefura W, HayGlass KT, Nickerson PW.
    Transplantation; 2010 Aug 27; 90(4):394-400. PubMed ID: 20625355
    [Abstract] [Full Text] [Related]

  • 19. Urine Angiotensin II Signature Proteins as Markers of Fibrosis in Kidney Transplant Recipients.
    Mohammed-Ali Z, Tokar T, Batruch I, Reid S, Tavares-Brum A, Yip P, Cardinal H, Hébert MJ, Li Y, Kim SJ, Jurisica I, John R, Konvalinka A.
    Transplantation; 2019 Jun 27; 103(6):e146-e158. PubMed ID: 30801542
    [Abstract] [Full Text] [Related]

  • 20. High tacrolimus clearance - a risk factor for development of interstitial fibrosis and tubular atrophy in the transplanted kidney: a retrospective single-center cohort study.
    Egeland EJ, Reisaeter AV, Robertsen I, Midtvedt K, Strøm EH, Holdaas H, Hartmann A, Åsberg A.
    Transpl Int; 2019 Mar 27; 32(3):257-269. PubMed ID: 30252957
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.